Incidence, prevalence and mortality of idiopathic pulmonary fibrosis in England from 2008 to 2018: a cohort study thorax.bmj.com/content/early/… Peter George SPH- Respiratory electronic health records

It is a great honor to visit London and my first scientific home for Respiratory Medicine!!! Join us tomorrow at 1pm British time ! 2pm CET thanks to Prof Wells and Peter George for organising! Pilar Rivera-Ortega MathioudakisAG maria molina molina Corlateanu Alexandru Juan I Enghelmayer 2022🇦🇷

Exciting 2 yr research nurse position open to work on ⁦Medical Research Council⁩ funded #bronchiectasis human rhinovirus challenge study with large team ⁦Aran Singanayagam⁩ ⁦James D Chalmers⁩ ⁦Tom Wilkinson⁩ and more. RT and DM if interested pls!! imperial.ac.uk/jobs/search-jo…

Introducing our new ERS publications Clinical research collaboration focussed on #AMR in #lung disease. Exciting new patient survey about to launch in collaboration with European Lung Foundation . Please follow and RT. Details to follow shortly! Anand Shah Amelia Shoemark

Editorial Epidemiology of idiopathic pulmonary fibrosis: opportunities and hurdles for population-level studies of rare disease. thorax.bmj.com/content/79/7/6…

This partnership between BRAINOMIX and Boehringer Ingelheim is a major milestone as AI-powered technology is integrated into the patient pathway. We will showcase how cutting edge interpretation of CT imaging can result in improved outcomes for our patients

Session ID 12 Early diagnosis and management of interstitial lung diseases - € (Fully booked) - looking forward to chairing this session with maria molina molina. If you are attending send me a like to say hello! #ERSCongress Great presentations from Peter George Pilar Rivera-Ortega

Thanks to ERS for inviting us to talk at this fully booked postgraduate course, ILD IPF Doc: Nazia Chaudhuri Pilar Rivera-Ortega Argyris Tzouvelekis Peter George Maria Molina-Molina, George Margaritopoulps and Claudia Ravaglia

Great presentations and discussion in Breaking News in ILD! #ERSCongress2024 ERS Assembly 12 - ILD

A star studded MDT panel on Dysphagia with Anais Rameau, Grainne Brady, Peter George swallaceobeslt Dr Justin Roe at BLA this afternoon

Our patients with IPF are being referred for palliative care far too late, if at all. Socioeconomic factors clearly a barrier and we need to do better with education and resource provision Dr. Kathleen Lindell Royal Brompton and Harefield NHLI

Peter George Congrats on the publication! We have lots of work to do - especially to meet the WHO statement endorsing #palliative-care. Great early step sharing this work!

ERJOR: e-Lung is an AI-powered technology that provides prognostic information from a baseline standard CT scan and, with a defined minimally clinical important difference, is more sensitive to serial change than conventional tools in the assessment of IPF bit.ly/3VEuPMI

New publications from our team: commonly prescribed medications and risk of pneumonia and all cause mortality in an IPF population pneumonia.biomedcentral.com/articles/10.11… Regular prescribing of PPIs and ICS was positively associated with hospitalisation for pneumonia Peter George

New postdoc position investigating interstitial lung abnormalities (ILA) and mechanisms driving early lung fibrosis King's Faculty of Life Sciences & Medicine Royal Brompton and Harefield Guy's and St Thomas' The Crick Please do consider applying: jobs.ac.uk/job/DLS668/pos… Closing date 18th Feb.

Brainomix Completes £14M ($18M) Series C Round to Advance Its Transformative AI Imaging Technology in Healthcare prnewswire.co.uk/news-releases/…

Excited for another busy #ATS2025, with Peter George and Prof Anand Devaraj presenting the latest evidence for our FDA-cleared e-Lung technology, which has been robustly validated in the #INBUILD study to identify progressive pulmonary fibrosis accurately and sensitively.

✅ e-Lung is robustly validated in the #INBUILD study to identify progressive pulmonary fibrosis accurately and sensitively ✅ e-Lung helps to identify patients at risk of progressive pulmonary fibrosis We hope to see you in San Francisco! 🌉 Peter George American Thoracic Society (ATS)

Our new study in eBioMedicine shows that higher baseline hsCRP predicts 20-year cardiovascular events & mortality in hypertensive patients. doi.org/10.1016/j.ebio…. Congratulations to Adam Hartley and the Imperial NHS 💙 Imperial College London team. British Heart Foundation Wellcome National Institute for Health and Care Research

New postdoc position in my lab investigating interstitial lung abnormalities (ILA) and mechanisms driving early lung fibrosis King's Faculty of Life Sciences & Medicine Royal Brompton and Harefield Guy's and St Thomas' The Francis Crick Institute Please do consider applying: my.corehr.com/pls/coreportal… Closing date 7th August.